Study: Open Access Trial Data Underutilized

Across three open data platforms offering more than 3,000 clinical trials, only 15.5% were requested by a small number of researchers over the course of 2 years, according to a new study. Only 505 unique trials had ever been requested, including 356 phase III trials, or 24.7% of available phase III trials, reported Ann Marie Navar, MD, PhD, MHS, of Duke University Medical Center in Durham, N.C., and colleagues.